Fatigue News and Research

RSS

Combination therapy places no greater burden on early-stage breast cancer patients

Adding an immune checkpoint inhibitor to the standard chemotherapy regimen for patients with early-stage breast cancer places no greater burden on patients' ability to perform day-to-day activities than chemotherapy alone, new research by Dana-Farber/Brigham and Women's Cancer Center investigators shows.

10 Dec 2020

Researchers receive $651,997 funding to study memory dysfunction in MS

Researchers at Montclair State University and Kessler Foundation have received funding totaling $651,997 from the National Multiple Sclerosis Society to measure memory-related abilities in individuals with and without multiple sclerosis (MS) for clues to how such cognitive processes are altered by MS. Joshua Sandry, PhD, assistant professor of psychology at Montclair State and Ekaterina Dobryakova, PhD, research scientist in the Center for Traumatic Brain Injury Research at Kessler Foundation, collaborate on the 4-year study, titled "Neuroimaging of Hippocampally Mediated Memory Dysfunction in Multiple Sclerosis."

10 Dec 2020

Physicians don't always recognize radiation therapy side effects in cancer patients

Physicians did not recognize side effects from radiation therapy in more than half of breast cancer patients who reported a significant symptom, a new study finds.

9 Dec 2020

Symptom under-recognition may be common in breast cancer patients treated with radiotherapy

Among patients with breast cancer treated with radiotherapy, under-recognition of symptoms was common in reports of pain, pruritus, edema, and fatigue, with younger patients and Black patients having significantly increased odds of symptom under-recognition, according to data presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.

9 Dec 2020

People with Bartonella infection exhibit neuropsychiatric symptoms, skin lesions

Bartonella bacteria are increasingly recognized as an emerging infectious disease threat. A new study by North Carolina State University researchers has found additional instances of Bartonella infection in humans who exhibited neuropsychiatric symptoms, a subset of whom also had skin lesions.

8 Dec 2020

Troublesome COVID-19 symptoms could last more than 6 weeks

Physicians in Geneva have shown that some of the troublesome symptoms of COVID-19 could last more than 6 weeks, even in patients without underlying risk factors.

8 Dec 2020

Tension between awareness and fatigue can shift the shape of coronavirus pandemic

In the midst of the coronavirus pandemic, two human factors are battling it out: awareness of the virus's severe consequences and fatigue from nine months of pandemic precautions.

8 Dec 2020

Phase I/IIA open-label study presents encouraging results on hard-to-treat AML subtypes

Novel menin-KMT2A inhibitor appears to be safe and well-tolerated. FLT3 inhibitor plus low-dose chemotherapy shows promising efficacy and safety. Results represent encouraging news on hard-to-treat AML subtypes.

7 Dec 2020

Combination of venetoclax and standard therapies shows promise in high-risk myeloid blood cancers

The novel oral drug venetoclax can be safely added to standard therapies for some high-risk myeloid blood cancers and in early studies the combination shows promise of improved outcomes, say scientists from Dana-Farber Cancer Institute.

7 Dec 2020

After a deadly COVID outbreak, Maryland County takes steps to protect health workers

A Maryland health department is taking new steps to protect its workers six months after a COVID-19 outbreak killed a veteran employee who was twice denied permission to work from home.

4 Dec 2020

NYC hospital workers, knowing how bad it can get, brace for COVID 2nd wave

No single municipality in the country suffered more in the first wave of the pandemic than New York City, which saw more than 24,000 deaths, mainly in the spring. Medical staff in New York know precisely how difficult and dangerous overwhelmed hospitals can be and are braced warily as infections begin to rise again.

3 Dec 2020

Combination of exercise and mindfulness training can help alleviate fatigue in cancer survivors

Researchers at the University of Illinois Urbana-Champaign have found that a combination of exercise and mindfulness training can help reduce fatigue in breast cancer survivors.

2 Dec 2020

NMR-based diagnostic tool could be used to detect fatty liver disease or liver fibrosis

About 25 percent of the U.S. population suffers from fatty liver disease, a condition that can lead to fibrosis of the liver and, eventually, liver failure.

2 Dec 2020

Data modeling study assesses effectiveness of NPIs in reducing COVID-19 reproduction number worldwide

As a second wave of the COVID-19 pandemic hits many regions worldwide, a new study reports a method to monitor the effective reproduction number (Re) in near real-time.

2 Dec 2020

Study demonstrates safety of novel immuno-oncology therapy in patients with advanced solid tumors

A novel therapy designed to help stimulate the body's immune system response against cancer appears to be safe to use as alone or in combination with immune checkpoint inhibitors.

1 Dec 2020

Fibromyalgia during COVID-19, anxiety and pain

Early research on the impact of the COVID-19 pandemic found persistent related anxiety in the general population. Researchers in the UK hypothesized that this anxiety would be associated with increased pain in chronic pain patients diagnosed with fibromyalgia (FM).

30 Nov 2020

Researchers reveal how SARS-CoV-2 reaches the brain

Using post-mortem tissue samples, a team of researchers from Charité - Universitätsmedizin Berlin have studied the mechanisms by which the novel coronavirus can reach the brains of patients with COVID-19, and how the immune system responds to the virus once it does.

30 Nov 2020

Fatigue News and Research

Combination therapy places no greater burden on early-stage breast cancer patients

Researchers receive $651,997 funding to study memory dysfunction in MS

Physicians don't always recognize radiation therapy side effects in cancer patients

Symptom under-recognition may be common in breast cancer patients treated with radiotherapy

People with Bartonella infection exhibit neuropsychiatric symptoms, skin lesions

Troublesome COVID-19 symptoms could last more than 6 weeks

Tension between awareness and fatigue can shift the shape of coronavirus pandemic

Phase I/IIA open-label study presents encouraging results on hard-to-treat AML subtypes

Combination of venetoclax and standard therapies shows promise in high-risk myeloid blood cancers

After a deadly COVID outbreak, Maryland County takes steps to protect health workers

NYC hospital workers, knowing how bad it can get, brace for COVID 2nd wave

Combination of exercise and mindfulness training can help alleviate fatigue in cancer survivors

NMR-based diagnostic tool could be used to detect fatty liver disease or liver fibrosis

Data modeling study assesses effectiveness of NPIs in reducing COVID-19 reproduction number worldwide

Study demonstrates safety of novel immuno-oncology therapy in patients with advanced solid tumors

Fibromyalgia during COVID-19, anxiety and pain

Researchers reveal how SARS-CoV-2 reaches the brain

Adding exercise to genetic treatment reverses fatigue in mice with common myotonic dystrophy

First meta-analysis looks at the impact of meditation, yoga, and mindfulness on concussions

Lungs of COVID-19 patients show good recovery in most cases

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News